Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News enVVeno Medical Corp NVNO

Healthcare Medical Devices

enVVeno Medical Corporation is a late-stage clinical med-tech company. The Company is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company is developing surgical and non-surgical replacement venous valves for patients suffering from severe Chronic Venous Insufficiency (CVI) of the deep venous system... see more

Add To Watchlist

Recent & Breaking News (NDAQ:NVNO)

Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present Updated VenoValve Data Next Week at the 32nd Annual Meeting of the American Venous Forum

Accesswire February 26, 2020

Hancock Jaffe Reports Positive Results for 6 Month CoreoGraft Animal Feasibility Study

Accesswire January 8, 2020

VenoValve Abstract Published in January 2020 Edition of Journal of Vascular Surgery

Accesswire December 20, 2019

Hancock Jaffe Medical Team to Make Presentations at 46th Annual VEITH Vascular Symposium November 19 to November 23 in New York City

Accesswire November 19, 2019

Hancock Jaffe Enrolls and Successfully Implants Tenth VenoValve Patient

Accesswire November 15, 2019

Principal Investigator Dr. Jorge Hernando Ulloa Presents 6 Month VenoValve Data at the 20th Congress of Asian Society for Vascular Surgery

Accesswire October 24, 2019

Principal Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Six Month Data at the 20th Congress of Asian Society for Vascular Surgery on October 25, 2019

Accesswire October 22, 2019

Hancock Jaffe to Present at the Inaugural MicroCap Rodeo Investor Conference on October 16, 2019

Accesswire October 14, 2019

Hancock Jaffe to Host Virtual Roadshow Webinar on Thursday, October 3, 2019 at 4:30 p.m. Eastern Time

Accesswire September 26, 2019

Hancock Jaffe Appoints Global Healthcare Executive Matthew Jenusaitis and Financial and Medical Reimbursement Expert Robert Gray to its Board of Directors

Accesswire September 16, 2019

Hancock Jaffe Medical Advisory Board Member Dr. Steven Elias Presents at International Union of Phlebology Conference in Krakow, Poland

Accesswire August 29, 2019

Hancock Jaffe to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019

Accesswire August 27, 2019

Hancock Jaffe Successfully Completes Two Additional VenoValve Implantations for First-in-Man Study

Accesswire August 20, 2019

Principle Investigator Dr. Jorge Hernando Ulloa Reports New 90 Day VenoValve Data at the Second Annual Society of Vascular and Endovascular Surgery Congress of Central America and the Caribbean

Accesswire July 26, 2019

Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present New 90 Day VenoValve Data at the Second Annual Society of Vascular and Endovascular Surgery Congress of Central America and the Caribbean On July 25, 2019

Accesswire July 19, 2019

Hancock Jaffe Reports Early Positive Results For CoreoGraft Animal Feasibility Study

Accesswire June 27, 2019

Primary Investigator Dr. Jorge Hernando Ulloa Reports New and Updated VenoValve Data at C3 Global Conference

Accesswire June 24, 2019

Hancock Jaffe Hires Brian Roselauf as Director of Research and Development

Accesswire June 20, 2019

Hancock Jaffe Primary Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Report at the Venous Summit at the C3 Global Conference

Accesswire June 19, 2019

Hancock Jaffe Successfully Completes VenoValve Implantation for First-in-Human Study

Accesswire June 13, 2019